Integra Lifesciences HLD (iart 0.5 08/15/25)

13F holders, Q2 2024 (June 30)
6holders −2
0new positions
2sold out
$0.92avg. 13F price*

At the end of Q2 2024, 6 institutions reported holding Integra Lifesciences HLD (iart 0.5 08/15/25) in their 13F filings, down 2 from Q1 2024. 0 opened new positions and 2 sold out. The largest holders were BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.8M), Ofi Invest Asset Management ($2.2M) and Liberty Mutual Group Asset Management Inc. ($1.4M).

Company
Integra Lifesciences HLD (iart 0.5 08/15/25)
CUSIP
457985AM1
Latest filing quarter
Q2 2025

History

Number of 13F holders

02468 Q1 2024: 8Q1 2024Q2 2024: 6Q2 2024Q3 2024: 3Q3 2024Q4 2024: 2Q4 2024Q1 2025: 1Q1 2025Q2 2025: 2Q2 2025

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions0$0
Exits2$640K

All 13F filers, Q1 2024 → Q2 2024: 74,000 shares bought and 5,868,961 shares sold, net −5,794,961 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 6 holders

BNP PARIBAS ASSET MANAGEMENT Holding S.A. 0.01% Reduce -33.3% 3,000,000 $2.8M
Ofi Invest Asset Management 0.06% Reduce -62.2% 2,500,000 $2.2M
Liberty Mutual Group Asset Management Inc. 0.20% No change 1,475,000 $1.4M
Oppenheimer Asset Management Inc. 0.00% Add +69.8% 180,000 $169K
Stephens Inc. 0.00% Reduce -2.0% 99,000 $93K
Northwestern Mutual Wealth Management Co. 0.00% No change 12,000 $11K

"% of holder's portfolio" is INTEGRA LIFESCIENCES HLD (IART 0.5 08/15/25)'s weight in each manager's 13F, not the share of Integra Lifesciences HLD (iart 0.5 08/15/25) the manager owns.